Triple‐negative breast cancers (TNBC), defined by the lack estrogen (ER) and progesterone receptor (PR) expression, as well as no Human Epidermal Growth Factor Receptor 2 (HER2) overexpression/amplification, represent 15% of breast cancer overall [1, 2]. The gene discussed is ERBB2; the disease is breast cancer.